AAP Releases 2019 Childhood Immunization Schedules
Influenza row modified to reflect current recommendations for live attenuated flu vaccine
Compounded Topical Pain Creams No Better Than Placebo
At one month, no significant difference seen in positive outcomes for treatment vs. control
Evidence of Therapeutic Efficacy Substantial for Cannabis Use
Substantial, conclusive evidence of therapeutic efficacy found for 85.5 percent of qualifying conditions
After Elbow Surgery, Children May Be Overprescribed Opioids
Patients who had supracondylar humerus fracture sx used less than 25 percent of prescribed drugs
Tofacitinib Benefits Sustained for Two Years in Patients With RA
Safety, tolerability through 24 months was consistent with 12-month tofacitinib analysis
CDC Examines Safety of Recombinant Zoster Vaccine
Total of 4,381 reports of adverse events during first eight months of use; 3 percent were serious
Expanded Recall of Warfarin Level Monitoring Test Strips
Inaccurate results may put patients at risk for serious injury or death
January 2019 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for January 2019. This roundup includes the latest...
Longitudinal TNF Levels Mainly Stable With Adalimumab in RA
Early low TNF strongly associated with formation of antidrug antibodies, may predict nonresponse
Pharmacist-Led Phone Follow-Up May Cut Readmission Rates
Intervention for polypharmacy patients linked to improved readmission rates, time to readmission
